Communications Medicine (May 2022)

Melanoma-specific antigen-associated antitumor antibody reactivity as an immune-related biomarker for targeted immunotherapies

  • Annika Rähni,
  • Mariliis Jaago,
  • Helle Sadam,
  • Nadežda Pupina,
  • Arno Pihlak,
  • Jürgen Tuvikene,
  • Margus Annuk,
  • Andrus Mägi,
  • Tõnis Timmusk,
  • Amir M. Ghaemmaghami,
  • Kaia Palm

DOI
https://doi.org/10.1038/s43856-022-00114-7
Journal volume & issue
Vol. 2, no. 1
pp. 1 – 11

Abstract

Read online

Rähni et al profile antibody response in patients with varied response to cancer immunotherapies. They identify antibody epitope responses that predict anti-cancer immunity elicited by immunotherapy.